Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-07-21
2011-12-13
Sullivan, Peter O (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C564S092000
Reexamination Certificate
active
08076376
ABSTRACT:
Aniline sulfonamide derivatives according to formula I have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders:where R1, R2, R3, R4, R5, R6, and L are set forth in the description.
REFERENCES:
patent: 2002/0048572 (2002-04-01), Shan et al.
patent: 2002/0119521 (2002-08-01), Palli et al.
patent: 2003/0073614 (2003-04-01), Schulman et al.
patent: 2003/0162758 (2003-08-01), Schwartz et al.
patent: 2003/0229062 (2003-12-01), Schwartz et al.
patent: 2004/0018560 (2004-01-01), Bledsoe et al.
patent: 2377999 AA (2001-01-01), None
patent: 2438133 AA (2002-08-01), None
patent: 2003267969 (2003-09-01), None
patent: 2004500332 (2004-01-01), None
patent: 2004524027 (2004-08-01), None
patent: 2004533216 (2004-11-01), None
patent: WO0054759 (2000-09-01), None
patent: WO 01/03705 (2001-01-01), None
patent: WO01/70816 (2001-09-01), None
patent: WO 01/82917 (2001-11-01), None
patent: WO 02/066612 (2002-08-01), None
patent: WO 02/066615 (2002-08-01), None
patent: WO03/049685 (2003-06-01), None
patent: WO03063576 (2003-08-01), None
patent: WO03082198 (2003-10-01), None
patent: WO2004058175 (2004-07-01), None
patent: WO2004058819 (2004-07-01), None
patent: WO 2004/065351 (2004-08-01), None
patent: WO 2004/089896 (2004-10-01), None
patent: WO2004098506 (2004-11-01), None
patent: WO2004101776 (2004-11-01), None
patent: WO2004104224 (2004-12-01), None
International Search Report for PCT Application No. PCT/US2006/028059 mailed on Nov. 13, 2006.
Li, Leping, et al., Discovery and Optimization of a novel series of liver X receptor-agonists, Bioorganic & Medicinal Chemistry Letters 16 (2006) 1638-1642.
Stein, et al., LXR Activation and Cholesterol Efflux from a Lipoprotein Depot in vivo, Biochimica et Biophysica Acta (2004), vol. 1686 (1-2), pp. 24-29.
Fukuchi, et al., Antiproliferative Effect of Liver X Receptor Agonists on LNCaP Human Prostate Cancer Cells, Cancer Research (2004), vol. 64(21), pp. 7686-7689.
Jakel, et al., The Liver X Receptor Ligand T0901317 Down-regulates APOA5 Gene Expression through Activation of SREBP-1c, Journal of Biological Chemistry (2004), vol. 279(44), pp. 45462-45469.
Quinet, et al., Gene-selective Modulation by a Synthetic Oxysterol Ligand of the Liver X Receptor, Journal of Lipid Research, (2004), vol. 45(10), pp. 1929-1942.
Houck, et al., T0901317 is a Dual LXR/FXR Agonist, Molcular Genetics and Metabolism, (2004), vol. 83(1/2), pp. 184-187.
Miao, et al., Raising HDL Cholesterol Without Inducing Hepatic Steatosis and Hypertriglyceridemia by a Selective LXR Modulator, Journal of Lipid Research, (2004), vol. 45(8), pp. 1410-1417.
Liang, et al., Liver X Receptors (LXRs) Regulate Apolipoprotein AIV-Implications of the Antiatherosclerotic Effect of LXR Agonists, Molecular Endocrinology, (2004), vol. 18(8), pp. 2000-2010.
Schmuth, et al., The Effect of LXR Activators on AP-1 Proteins in Keratinocytes, Journal of Investigative Dermatology, (2004), vol. 123(1), pp. 41-48.
Beyer, et al., Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Denisty Lipoprotein and Triglyceride Metabolism in Vivo, Journal of Pharmacology and Experimental Therapeutics, (2004), vol. 309(3), pp. 861-868.
Toresson, et al., Purification of Functional Full-Length Liver X Receptor β Produced inEscherichia coli, Protein Expression and Purification, (2004), vol. 35(2), pp. 190-198.
Seo, et al., Activated Liver X Receptors Stimulate Adipocyte Differentiation Through Induction of Peroxisome Proliferator-Activated Receptor γ Expression, Molecular and Cellular Biology, (2004), vol. 24(8), pp. 3430-3444.
Masson, et al., Cholesteryl Ester Transfer Protein Modulates the Effect of Liver X Receptor Agonists on Cholesterol Transport and Excretion in the Mouse, Journal of Lipid Research, (2004), vol. 45(3), pp. 543-550.
Liang, et al., A Liver X Receptor and Retinoid X Receptor Heterodimer Mediates Apolipoprotein E Expression, Secretion and Cholesterol Homeostasis in Astrocytes, Journal of Neurochemistry, (2004), vol. 88(3), pp. 623-634.
Chisholm, et al., The LXr Ligand T0901317 Induces Severe Lipogenesis in the db/db Diabetic Mouse, Journal of Lipid Research, (2003), vol. 44(11), pp. 2039-2048.
Hoerer, et al., Crystal Structure of the Human Liver X Receptor β Ligand-Binding Domain in Complex with a Synthetic Agonist, Journal of Molecular Biology, (2003), vol. 334(5), pp. 853-861.
Rowe, et al., Enhanced Synthesis of the Oxysterol 24(S), 25-Epoxycholesterol in Macrophages by Inhibitors of 2,3-Oxidosqualene: Lanosterol Cyclase, Circulation Research, (2003), vol. 93(8), pp. 717-725.
Faernegardh, et al., The Three-Dimensional Structure of the Liver X Receptor β Reveals a Flexible Ligand-Binding Pocket That Can Accommodate Fundamentally Different Ligands, Journal of Biological Chemistry, (2003), vol. 278(40), pp. 38821-38828.
Svensson, et al., Crystal Structure of the Heterodimeric Complex of LXRα and Rxrβ Ligand-Binding Domains in a Fully Agonistic Conformation, EMBO Journal, (2003), vol. 22(18), pp. 4625-4633.
Kaneko, et al., Induction of Intestinal ATP-Binding Cassette Transporters by a Phytosterol-Derived Liver X Receptor Agonist, Journal of Biological Chemistry, (2003), vol. 278(38), pp. 36091-36098.
Miyazaki, et al., Identification and Characterization of Murine SCD4, a Novel Heart-Specific Stearoyl-CoA Desaturase lsoforrn Regulated by Leptin and Dietary Factors, Journal of Biological Chemistry, (2003), vol. 278(36), pp. 33904-33911.
Wang, et al., Molecular Determinants of LXRα Agonism, Journal of Molecular Graphics & Modelling, (2003), vol. 22(2), pp. 173-181.
Williams, et al., X-ray Crystal Structure of the Liver X Receptor β Ligand Binding Domain: Regulation by a Histidine-Tryptophan Switch, Journal of Biological Chemistry, (2003), vol. 278(29), pp. 27138-27143.
Yoshikawa, et al., Cross-Talk Between Peroxisome Proliferator-Activated Receptor (PPAR) α and Liver X Receptor (LXR) in Nutritional Regulation of Fatty Acid Metabolism. I. PPARs Suppress Sterol Regulatory Element Binding Protein-1c Promoter Through Inhibition of LXR Signaling, Molecular Endocrinology, (2003), vol. 17(7), pp. 1240-1254.
Perez, et al., Expression of Nuclear Receptors and Apo E Secretion During the Differentiation of Monocytic THP-1 Cells Into Macrophages, Cell Biology and Toxicology, (2003), vol. 19(2), pp. 95-105.
Goodwin, et al., Differential Regulation of Rat and Human CYP7A1 by the Nuclear Oxysterol Receptor Liver X Receptor-α, Molecular Endocrinology, (2003), vol. 17(3), pp. 386-394.
Juvet, et al., On the Role of Liver X Receptors in Lipid Accumulation in Adipocytes, Molecular Endocrinology, (2003), vol. 17(2), pp. 172-182.
Terasaka, et al., T-0901317, a Synthetic Liver X Receptor Ligand, Inhibits Development of Atherosclerosis in LDL Receptor-Deficient Mice, FEBS Letters, (2003), vol. 536(1-3), pp. 6-11.
Kaplan, et al., Regulation of the Angiopoietin-Like Protein 3 Gene by LXR, Journal of Lipid Research, (2003), vol. 44(1), pp. 136-143.
Cao, et al., Antidiabetic Action of a Liver X Receptor Agonist Mediated by Inhibition of Hepatic Gluconeogenesis, Journal of Biological Chemistry, (2003), vol. 278(2), pp. 1131-1136.
Brendel, et al., The Small Heterodimer Partner Interacts With the Liver X Receptor α and Represses its Transcriptional Activity, Molecular Endocrinology, (2002), vol. 16(9), pp. 2065-2076.
Stulnig, et al., Liver X Receptors Downregulate 11β-hydroxysteroid Dehydrogenase Type 1 Expression and Activity, Diabetes, (2002), vol. 51(8), pp. 2426-2433.
Murthy, et al., LXR/RXR Activation Enhances Basolateral Efflux of Cholesterol in CaCo-2 Cells, Journal of Lipid Research, (2002), vol. 43(7), pp. 1054-1064.
Collins, et al., Identification of a Nonsteroidal Liver X Receptor Agonist Through Parallel Array Synthesis of Tertiary Amines, Journal of Medicinal Chemistry, (2002), vol. 45(10), pp. 1963-1966.
Song, et al., Hypolipidemic Effects of Selective Liver X Receptor Alpha Agonists, St
He Xiao
McMinn Dustin
Powers Jay P.
Rew Yosup
Sun Daqing
Lemoine Elsa D.
O Sullivan Peter
LandOfFree
Aniline sulfonamide derivatives and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aniline sulfonamide derivatives and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aniline sulfonamide derivatives and their uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4257115